Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Evie Yulin | President Director & Biopharma Director | -- | -- | 1967 |
Mr. Bambang Nurcahyo | Finance Director & Director | -- | -- | 1970 |
Eduan Tjong | Supply Chain & Operation Manager | -- | -- | -- |
Miranda Andamsari | Compliance Officer | -- | -- | -- |
Taufiq Wibowo | Head of Legal | -- | -- | -- |
Ms. Melisa Sandrianti | Corporate Secretary & Corporate Communications Manager | -- | -- | 1978 |
Aquira Kurniawati Moeladi | Human Resource Head | -- | -- | -- |
Mr. Arryo Aritrixso Teguh Putranto Wachjuwidajat | Plant Director & Independent Director | -- | -- | 1972 |
Ms. Pachita Ramadhani | Head of Internal Audit Unit & Sr Finance Manager | -- | -- | 1980 |
Bundi Jannius | Head of Site Pharma Tech | -- | -- | -- |
PT Merck Tbk
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 376
Description
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders, such as hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in Jakarta Timur, Indonesia. PT Merck Tbk operates as a subsidiary of Merck Holding GmbH.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 7, 2024 at 12:00 AM UTC
Ex-Dividend Date